Chemoinformaics analysis of 3-(2,4-DIHYDROXYPHENYL)-1-(4-HYDROXYPHENYL)PROP-2-EN-1-ONE
| Molecular Weight | 256.257 | nRot | 3 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 14 |
| Exact Molecular Weight | 256.074 | nRing | 2 |
| Solubility: LogS | -2.834 | nHRing | 0 |
| Solubility: LogP | 2.626 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 36.2595 |
| nHD | 3 | BPOL | 12.9065 |
| QED | 0.583 |
| Synth | 2.1 |
| Natural Product Likeliness | 0.548 |
| NR-PPAR-gamma | 0.242 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.008 |
| HIA | 0.015 |
| CACO-2 | -4.767 |
| MDCK | 0.0000125 |
| BBB | 0.066 |
| PPB | 0.988944 |
| VDSS | 0.549 |
| FU | 0.0116485 |
| CYP1A2-inh | 0.951 |
| CYP1A2-sub | 0.126 |
| CYP2c19-inh | 0.767 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.733 |
| CYP2c9-sub | 0.956 |
| CYP2d6-inh | 0.741 |
| CYP2d6-sub | 0.866 |
| CYP3a4-inh | 0.874 |
| CYP3a4-sub | 0.187 |
| CL | 13.25 |
| T12 | 0.919 |
| hERG | 0.036 |
| Ames | 0.703 |
| ROA | 0.874 |
| SkinSen | 0.949 |
| Carcinogencity | 0.654 |
| EI | 0.97 |
| Respiratory | 0.33 |
| NR-Aromatase | 0.826 |
| Antiviral | No |
| Prediction | 0.891259 |